Stay updated on PD-L1+ NSCLC Clinical Trial: Pembrolizumab Combo

Sign up to get notified when there's something new on the PD-L1+ NSCLC Clinical Trial: Pembrolizumab Combo page.
Latest website image capture
Clouds background image

Latest updates to the PD-L1+ NSCLC Clinical Trial: Pembrolizumab Combo page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Access to the study record now returns a 403 Forbidden page, with the site chrome visible but no study details. This indicates the page loads an access-denied response rather than the expected content.
    Difference
    19%
    Check dated 2026-09-20T22:24:10.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    The page now includes a new line '2023 ( U.S. NIH Grant/Contract )' under Other Study ID Numbers, and the page revision has been updated from v3.6.5 to v3.6.6 (the previous revision line was removed).
    Difference
    0.1%
    Check dated 2026-08-30T21:42:35.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    Plain Language Summary was removed from the study page, eliminating the layperson-friendly overview of the trial and its objectives.
    Difference
    0.0%
    Check dated 2026-08-16T15:33:55.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    An HTML error page was added, making the study record unavailable. Several core content sections and sponsor/IPD-related items were removed from the page, reducing the information available about the study.
    Difference
    17%
    Check dated 2026-08-09T08:57:49.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.3 to v3.6.4. This indicates an internal update to the page's metadata rather than any changes to the study content.
    Difference
    0.0%
    Check dated 2026-07-25T16:42:27.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.2 to v3.6.3, indicating a new published revision of the record. This appears to be a small, internal version update with no visible changes to the study details or data.
    Difference
    0.0%
    Check dated 2026-07-04T04:17:48.000Z thumbnail image

Stay in the know with updates to PD-L1+ NSCLC Clinical Trial: Pembrolizumab Combo

Enter your email address, and we'll notify you when there's something new on the PD-L1+ NSCLC Clinical Trial: Pembrolizumab Combo page.